LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/OA Clue Found in Alteration of Cell Behavior
Large Joints and Extremities

OA Clue Found in Alteration of Cell Behavior

September 10, 2014 1 min read Premium comments

Advertisement

OA Clue Found in Alteration of Cell Behavior
Heberden Nodes / Source: Wikimedia Commons and Milorad Dimic, M.D.
Secondary

A team of researchers from the University of Liverpool has found new information on how cells change their behavior at the onset of osteoarthritis (OA). The researchers, from the University’s Institute of Ageing and Chronic Disease, have learned that “changes in the rate at which molecules in joint cartilage (mRNA) are created and destroyed are fundamental to causing this change in behavior.”

By upsetting this balance—with more mRNA being destroyed—the cells cease to function as effectively.

Senior lecturer in orthopedic sciences, Dr. Simon Tew said in the September 4, 2014 news release, “Osteoarthritic cartilage cells have a significant number of genes whose mRNA is destroyed more rapidly than those in healthy cells. This affects some genes that we already know are involved in osteoarthritis as well as some that are less well studied.”

As indicated in the news release, the researchers compared cells from OA patients to those of healthy patients. The findings show how the cells in joints stop working properly, leading to arthritis and the researchers hope that by understanding this part of the process, new treatments can be developed which address the problem.

Dr. Tew concluded, “We’ve not discovered the cause of arthritis, but this does shed light on the process of how the disease manifests itself. To develop new drugs to treat one of the leading causes of disability requires the fullest possible understanding of the condition and this discovery is part of that overall picture.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy